OXIGENE INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: OXIGENE INC, 10-Q, 2000-11-14
Next: PMC COMMERCIAL TRUST /TX, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000908259
<NAME>                        Oxigene, Inc.
<MULTIPLIER>                  1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               DEC-31-2000
<PERIOD-START>                  JAN-01-2000
<PERIOD-END>                    SEP-30-2000
<CASH>                             29,259
<SECURITIES>                        1,426
<RECEIVABLES>                           0
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                   31,408
<PP&E>                                324
<DEPRECIATION>                       (130)
<TOTAL-ASSETS>                     34,015
<CURRENT-LIABILITIES>               1,490
<BONDS>                                 0
                   0
                             0
<COMMON>                              113
<OTHER-SE>                         24,009
<TOTAL-LIABILITY-AND-EQUITY>       34,015
<SALES>                                 0
<TOTAL-REVENUES>                    2,724
<CGS>                                   0
<TOTAL-COSTS>                           0
<OTHER-EXPENSES>                    9,728
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                    (7,004)
<INCOME-TAX>                            0
<INCOME-CONTINUING>                (7,004)
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                       (7,004)
<EPS-BASIC>                         (0.62)
<EPS-DILUTED>                       (0.62)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission